Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19

Ramtin Pourahmad; Bobak Moazzami; Nima Rezaei

doi:10.1007/s42399-020-00438-2

Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19

SN Compr Clin Med. 2020;2(9):1407-1411. doi: 10.1007/s42399-020-00438-2. Epub 2020 Jul 31.

Authors

Ramtin Pourahmad¹, Bobak Moazzami^{1

2}, Nima Rezaei^{1

2}

Affiliations

¹ Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
² Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Since the rapidly evolving outbreak of COVID-19, several empirical therapeutic options have been recommended including the use of antivirals, steroids, and vaccines. According to recent observations about different modalities in treatment of patients infected with COVID-19, plasmapheresis and intravenous immunoglobulin (IVIg) have been reported to be an effective empirical therapeutic option to control the infection. In this review, we aimed to provide an overview on the possible application of plasmapheresis and intravenous immunoglobulin in patients with COVID-19.

Keywords: COVID-19; Coronavirus; Intravenous immunoglobulin; Plasmapheresis; Treatment.

Publication types

Review